Follow
Brock L Schweitzer
Brock L Schweitzer
Oncocyte Corporation
Verified email at oncocyte.com
Title
Cited by
Cited by
Year
Regulation of the interleukin-7 receptor α promoter by the Ets transcription factors PU. 1 and GA-binding protein in developing B cells
RP DeKoter, BL Schweitzer, MB Kamath, D Jones, H Tagoh, C Bonifer, ...
Journal of Biological Chemistry 282 (19), 14194-14204, 2007
832007
Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
BZ Ring, DR Hout, SW Morris, K Lawrence, BL Schweitzer, DB Bailey, ...
BMC cancer 16 (1), 1-8, 2016
762016
Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo
CY Ni, ZH Wu, WC Florence, VV Parekh, MP Arrate, S Pierce, ...
The Journal of Immunology 180 (11), 7107-7111, 2008
642008
Analysis of gene expression and Ig transcription in PU. 1/Spi-B-deficient progenitor B cell lines
BL Schweitzer, RP DeKoter
The Journal of Immunology 172 (1), 144-154, 2004
632004
Reduction in PU. 1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality
IB Houston, MB Kamath, BL Schweitzer, TM Chlon, RP DeKoter
Experimental hematology 35 (7), 1056-1068, 2007
542007
Spi-C has opposing effects to PU. 1 on gene expression in progenitor B cells
BL Schweitzer, KJ Huang, MB Kamath, AV Emelyanov, BK Birshtein, ...
The Journal of Immunology 177 (4), 2195-2207, 2006
382006
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
B Jovanović, Q Sheng, RS Seitz, KD Lawrence, SW Morris, LR Thomas, ...
BMC cancer 17 (1), 1-14, 2017
302017
Performance of a RT-PCR assay in comparison to FISH and immunohistochemistry for the detection of ALK in non-small cell lung cancer
DR Hout, BL Schweitzer, K Lawrence, SW Morris, T Tucker, R Mazzola, ...
Cancers 9 (8), 99, 2017
242017
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for …
JR Espinosa Fernandez, BL Eckhardt, J Lee, B Lim, T Pearson, RS Seitz, ...
PloS one 15 (4), e0231953, 2020
222020
Transgenic expression of Spi‐C impairs B‐cell development and function by affecting genes associated with BCR signaling
X Zhu, BL Schweitzer, EJ Romer, CEW Sulentic, RP DeKoter
European journal of immunology 38 (9), 2587-2599, 2008
202008
A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
TJ Nielsen, BZ Ring, RS Seitz, DR Hout, BL Schweitzer
Heliyon 7 (3), e06438, 2021
192021
Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent …
DL Saltman, TJ Nielsen, D Salina, DR Hout, FB McMahon, BR Valev, ...
Therapeutic Advances in Medical Oncology 13, 17588359211010156, 2021
42021
One-year progression-free survival in lung cancer patients treated with immune checkpoint inhibitors is significantly associated with a novel immunomodulatory signature but not …
H Ranganath, A Jain, J Smith, J Ryder, A Chaudry, E Miller, F Hare, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
42019
KIT COMPRISING PRIMERS FOR AMPLIFYING ALK KINASE DOMAIN NUCLEIC ACIDS
DR Hout, R Skelton, J Handshoe, K Lawrence, B Schweitzer
US Patent 20,150,307,944, 2015
42015
A prospective study to compare qPCR to IHC and FISH for the detection of anaplastic lymphoma kinase (ALK) fusions in FFPE specimens from NSCLC patients (PCRTALK).
DR Hout, J Handshoe, B Schweitzer, SW Morris, A Karsan, H Daudt, ...
ASCO Annual Meeting Proceedings 32 (15_suppl), TPS11136, 2014
42014
Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.
T Iwase, L Pusztai, K Blenman, X Li, R Seitz, TJ Nielsen, BL Schweitzer, ...
Journal of Clinical Oncology 38 (15_suppl), 3117-3117, 2020
32020
Novel qPCR screen for efficient and reliable identification of RET fusion-positive non-small cell lung cancer.
BL Schweitzer, RB Smith, R Skelton, R Vincent, F McMahon, J Handshoe, ...
ASCO Annual Meeting Proceedings 33 (15_suppl), e22154, 2015
22015
Validation of a 27-gene immuno-oncology algorithm in metastatic urothelial carcinoma treated with an immune checkpoint inhibitor
RS Seitz, DT Ross, TJ Nielsen, DR Hout, BL Schweitzer
Cancer Research 81 (13 Supplement), 23-23, 2021
12021
Pathway modeling to translate the 27-gene immuno-oncology algorithm into bladder cancer
RS Seitz, TJ Nielsen, BL Schweitzer, DR Hout, DT Ross
Cancer Research 81 (13 Supplement), 175-175, 2021
12021
The unknown piece of the pie: Molecular markers in triple-negative lung cancer.
BL Schweitzer, KD Lawrence, J Handshoe, R Skelton, L Chatfield, L Xue, ...
Cancer Research 73 (8 Supplement), 1930-1930, 2013
12013
The system can't perform the operation now. Try again later.
Articles 1–20